home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

VEGF-C Prevents Internal Drowning

  December, 2 2003 7:44
your information resource in human molecular genetics
What prevents our tissues from drowning in their own fluid? Mammals develop a unique vascular network called the lymphatic system, which drains excess fluids from our tissues to prevent swelling of our extremities and helps to maintain our proper osmotic balance. In the January 2004 issue of Nature Immunology, researchers identify a critical factor, vascular endothelial growth factor C (VEGF-C), which is required to develop and maintain this drainage system.

Mice lacking VEGF-C die before birth due to distorted organ swelling. Even adult mice that harbor only one defective Vegfc gene copy still develop swollen paws and defects in immune cell trafficking throughout their bodies. Alitalo and colleagues find that VEGF-C provides the signal to form lymphatic veins, which are distinct from blood veins.

VEGF-C commands the cells that form these vessels to migrate in developing embryonic tissues and coalesce to form the lymphatics. The new results suggest that mutations in VEGFC might be responsible for a human genetic predisposition to lymphedema – a condition marked by gross swelling of the extremities. This work will enlighten our understanding of internal fluid containment and provide animal models to test potential future therapies for the treatment of patients with lymphedema.

Author Contact:

Kari Alitalo
University of Helsinki, Finland
Tel: +358 9 1912 5511
E-mail: kari.alitalo@helsinki.fi

Additional Contact For Comment On Paper:

Judah Folkman
Harvard Medical School
Boston, MA
Tel: +1 617 355 7661
E-mail: judah.folkman@tch.harvard.edu

Also available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.